DPP4 and respiratory tract infectious disorder: In our analysis, we did not detect high levels of co-expression of ACE2 and DPP4 in human lung tissue; however, both SARS-CoV-2 and MERS-CoV cause respiratory infections and associated disease symptoms in humans [48, 49].